Blog |

13 April 2021

The Access Blog

Jepngok Kiptui was just three when she was bitten by a snake while sleeping in her bed at home in Baringo County, North-Western Kenya. It took more than five hours to get her to the county’s main referral hospital, after being referred from two hospitals that lacked the capacity to treat her. Little Cheptui had to undergo three surgeries: the first to remove the dead tissues killed by the snake’s venom, and two skin grafting surgeries. Photograph by Paul Odongo

Blog |

09 February 2023

Tropical & neglected diseases

Snakebite reflecting on the neglected disease

Dilaram, a former TB-PRACTECAL clinical trial patient, in Nukus, Karakalpakstan, Uzbekistan.

Blog |

17 January 2023

New, shorter treatment brings hope for TB patient Dilaram

Clinical trials

Blog |

17 November 2022

How much do clinical trials cost? The answer is overdue.

Cabotegravir is a long-acting antiretroviral medicine used as for HIV prevention in people vulnerable to infection. © Isabel Corthier

Blog |

05 October 2022

Research and development

South Africa can and must demand better deals for drug clinical trials — lives depend on it

Because of superstition, people in South Sudan put dead snakes in trees after killing them, as they believe they may otherwise come back to life. But one of the most common snakes, the Puff Adder is never killed, as it veneered for religious reasons.

Blog |

16 September 2022

Tropical & neglected diseases

South Sudan

Why rapid treatment is essential after a snakebite: a story from South Sudan

Blog image cover

Blog |

24 August 2022

Vaccines

Access (or not) to vaccines for monkeypox in Africa: a sense of déjà vu?

Blog image cover

Blog |

22 June 2022

Tropical & neglected diseases

Starting over? A critical moment in the struggle against neglected tropical diseases

Blog image cover

Blog |

17 May 2022

COVID-19

Patently unfair: when climate justice aligns with access to medicines